Dr. Mukherjee on Radioactive Iodine Treatment of Thyroid Cancer and Risk of MDS
Sudipto Mukherjee, MD, associate staff, Department of Hematology and Oncology, Cleveland Clinic, discusses a study examining the association between radioactive iodine treatment of thyroid cancer and the risk of developing myelodysplastic syndromes (MDS).
